Cargando…
Mast Cell Activation Disorder and Postural Orthostatic Tachycardia Syndrome: A Clinical Association
BACKGROUND: Recently there has been increased interest in a possible association between mast cell activation (MCA) disorder and postural orthostatic tachycardia syndrome (POTS). This study examined the frequency with which symptoms and laboratory findings suggesting MCA disorder occurred in patient...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649306/ https://www.ncbi.nlm.nih.gov/pubmed/34398691 http://dx.doi.org/10.1161/JAHA.121.021002 |
_version_ | 1784610967890427904 |
---|---|
author | Kohno, Ritsuko Cannom, David S. Olshansky, Brian Xi, Shijun Cindy Krishnappa, Darshan Adkisson, Wayne O. Norby, Faye L. Fedorowski, Artur Benditt, David G. |
author_facet | Kohno, Ritsuko Cannom, David S. Olshansky, Brian Xi, Shijun Cindy Krishnappa, Darshan Adkisson, Wayne O. Norby, Faye L. Fedorowski, Artur Benditt, David G. |
author_sort | Kohno, Ritsuko |
collection | PubMed |
description | BACKGROUND: Recently there has been increased interest in a possible association between mast cell activation (MCA) disorder and postural orthostatic tachycardia syndrome (POTS). This study examined the frequency with which symptoms and laboratory findings suggesting MCA disorder occurred in patients diagnosed with POTS. METHODS AND RESULTS: Data were obtained from patients in whom symptoms and orthostatic testing were consistent with a POTS diagnosis. Individuals with <4 months symptom duration, evident ongoing inflammatory disease, suspected volume depletion, or declined consent were excluded. All patients had typical POTS symptoms; some, however, had additional nonorthostatic complaints not usually associated with POTS. The latter patients underwent additional testing for known MCA biochemical mediators including prostaglandins, histamine, methylhistamine, and plasma tryptase. The study comprised 69 patients who met POTS diagnostic criteria. In 44 patients (44/69, 64%) additional nonorthostatic symptoms included migraine, allergic complaints, skin rash, or gastrointestinal symptoms. Of these 44 patients, 29 (66%) exhibited at least 1 laboratory abnormality suggesting MCA disorder, and 11/29 patients had 2 or more such abnormalities. Elevated prostaglandins (n=16) or plasma histamine markers (n=23) were the most frequent findings. Thus, 42% (29/69) of patients initially diagnosed with POTS exhibited both additional symptoms and at least 1 elevated biochemical marker suggesting MCA disorder. CONCLUSIONS: Laboratory findings suggesting MCA disorder were relatively common in patients diagnosed with POTS and who present with additional nonorthostatic gastrointestinal, cutaneous, and allergic symptoms. While solitary abnormal laboratory findings are not definitive, they favor MCA disorder being considered in such cases. |
format | Online Article Text |
id | pubmed-8649306 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86493062022-01-14 Mast Cell Activation Disorder and Postural Orthostatic Tachycardia Syndrome: A Clinical Association Kohno, Ritsuko Cannom, David S. Olshansky, Brian Xi, Shijun Cindy Krishnappa, Darshan Adkisson, Wayne O. Norby, Faye L. Fedorowski, Artur Benditt, David G. J Am Heart Assoc Original Research BACKGROUND: Recently there has been increased interest in a possible association between mast cell activation (MCA) disorder and postural orthostatic tachycardia syndrome (POTS). This study examined the frequency with which symptoms and laboratory findings suggesting MCA disorder occurred in patients diagnosed with POTS. METHODS AND RESULTS: Data were obtained from patients in whom symptoms and orthostatic testing were consistent with a POTS diagnosis. Individuals with <4 months symptom duration, evident ongoing inflammatory disease, suspected volume depletion, or declined consent were excluded. All patients had typical POTS symptoms; some, however, had additional nonorthostatic complaints not usually associated with POTS. The latter patients underwent additional testing for known MCA biochemical mediators including prostaglandins, histamine, methylhistamine, and plasma tryptase. The study comprised 69 patients who met POTS diagnostic criteria. In 44 patients (44/69, 64%) additional nonorthostatic symptoms included migraine, allergic complaints, skin rash, or gastrointestinal symptoms. Of these 44 patients, 29 (66%) exhibited at least 1 laboratory abnormality suggesting MCA disorder, and 11/29 patients had 2 or more such abnormalities. Elevated prostaglandins (n=16) or plasma histamine markers (n=23) were the most frequent findings. Thus, 42% (29/69) of patients initially diagnosed with POTS exhibited both additional symptoms and at least 1 elevated biochemical marker suggesting MCA disorder. CONCLUSIONS: Laboratory findings suggesting MCA disorder were relatively common in patients diagnosed with POTS and who present with additional nonorthostatic gastrointestinal, cutaneous, and allergic symptoms. While solitary abnormal laboratory findings are not definitive, they favor MCA disorder being considered in such cases. John Wiley and Sons Inc. 2021-08-16 /pmc/articles/PMC8649306/ /pubmed/34398691 http://dx.doi.org/10.1161/JAHA.121.021002 Text en © 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Research Kohno, Ritsuko Cannom, David S. Olshansky, Brian Xi, Shijun Cindy Krishnappa, Darshan Adkisson, Wayne O. Norby, Faye L. Fedorowski, Artur Benditt, David G. Mast Cell Activation Disorder and Postural Orthostatic Tachycardia Syndrome: A Clinical Association |
title | Mast Cell Activation Disorder and Postural Orthostatic Tachycardia Syndrome: A Clinical Association |
title_full | Mast Cell Activation Disorder and Postural Orthostatic Tachycardia Syndrome: A Clinical Association |
title_fullStr | Mast Cell Activation Disorder and Postural Orthostatic Tachycardia Syndrome: A Clinical Association |
title_full_unstemmed | Mast Cell Activation Disorder and Postural Orthostatic Tachycardia Syndrome: A Clinical Association |
title_short | Mast Cell Activation Disorder and Postural Orthostatic Tachycardia Syndrome: A Clinical Association |
title_sort | mast cell activation disorder and postural orthostatic tachycardia syndrome: a clinical association |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649306/ https://www.ncbi.nlm.nih.gov/pubmed/34398691 http://dx.doi.org/10.1161/JAHA.121.021002 |
work_keys_str_mv | AT kohnoritsuko mastcellactivationdisorderandposturalorthostatictachycardiasyndromeaclinicalassociation AT cannomdavids mastcellactivationdisorderandposturalorthostatictachycardiasyndromeaclinicalassociation AT olshanskybrian mastcellactivationdisorderandposturalorthostatictachycardiasyndromeaclinicalassociation AT xishijuncindy mastcellactivationdisorderandposturalorthostatictachycardiasyndromeaclinicalassociation AT krishnappadarshan mastcellactivationdisorderandposturalorthostatictachycardiasyndromeaclinicalassociation AT adkissonwayneo mastcellactivationdisorderandposturalorthostatictachycardiasyndromeaclinicalassociation AT norbyfayel mastcellactivationdisorderandposturalorthostatictachycardiasyndromeaclinicalassociation AT fedorowskiartur mastcellactivationdisorderandposturalorthostatictachycardiasyndromeaclinicalassociation AT bendittdavidg mastcellactivationdisorderandposturalorthostatictachycardiasyndromeaclinicalassociation |